Safety Assessment of a 1940 nm Tm:YAP Laser for Fractional Skin Ablation in a Swine Model
Lasers in Surgery and Medicine · 2025
DOI: 10.1002/lsm.70022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lasers in Surgery and Medicine, 2025. Verfasst von Yuval Ramot und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hadassah Medical Center, Jerusalem, Israel. Hauptthemen laut MEDLINE: Lasers, Solid-State, Skin, Laser Therapy. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The study was funded by LaserTeam Ltd., Jerusalem, Israel and supported by the Israel Innovation Authority (Grant No. 73276)..
Abstract (Originalsprache)
Objectives
This exploratory study was aimed to evaluate the safety and preliminary efficacy of Epicare, a 1940 nm thulium‐doped yttrium aluminum perovskite (Tm:YAP) laser, for fractional skin ablation in a swine model. The goal was to assess collagen remodeling and tissue responses across varied laser settings to optimize skin resurfacing applications. Materials and Methods Two female domestic swine were subjected to controlled fractional laser ablation using Epicare across 52 marked abdominal sites with varying energy settings. Macroscopic examinations of ablated sites were conducted immediately following ablation and at 1, 3, 7, 14, 22, and 29 days postablation. Histopathological evaluation was conducted immediately posttreatment, and at 1, 7, and 29 days postablation. Observed parameters included epidermal regeneration, dermal remodeling, inflammation, and collagen deposition.
Results
Macroscopic evaluations revealed a fractional, clear, and immediate impact of ablation, consisting primarily of erythema and edema, which resolved without complications by Day 14. Histopathological analysis indicated focal, cylinder‐like structures associated with necrotic epidermis and dermis, which healed progressively (i.e. from day 1), transitioning to complete epidermal regeneration by Day 7 for most energy settings. By Day 29, advanced collagen deposition and no residual inflammation indicated effective dermal remodeling, consistent with rapid healing and minimal adverse reactions.
Conclusions
Epicare demonstrated a favorable safety profile and effective tissue ablation. These findings support the laser's potential for dermatologic applications while emphasizing the need for further investigation to confirm its efficacy and optimal settings in human clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Hadassah Medical Center, Jerusalem, Israel.
- The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Preclinical Consultant, Rehovot, Israel.
- LAHAV CRO, Kibbutz Lahav, Israel.
- Laser Team Medical Ltd., Jerusalem, Israel.
- Department of Applied Physics, Electro-Optics Engineering Faculty, Jerusalem College of Technology, Jerusalem, Israel.
Förderung
- The study was funded by LaserTeam Ltd., Jerusalem, Israel and supported by the Israel Innovation Authority (Grant No. 73276).
Zitieren
APA
Ramot, Y., Steiner, M., Vazana, U., Nahear, R., Suliman, N., Friedman, D. J., Noach, S., & Nyska, A. (2025). Safety Assessment of a 1940 nm Tm:YAP Laser for Fractional Skin Ablation in a Swine Model. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.70022
Vancouver
Ramot Y, Steiner M, Vazana U, Nahear R, Suliman N, Friedman DJ, et al. Safety Assessment of a 1940 nm Tm:YAP Laser for Fractional Skin Ablation in a Swine Model. Lasers in Surgery and Medicine. 2025. doi:10.1002/lsm.70022
BibTeX
@article{Ramot2025,
author = {Ramot, Yuval and Steiner, Michal and Vazana, Udi and Nahear, Rotem and Suliman, Neria and Friedman, David J and Noach, Salman and Nyska, Abraham},
title = {Safety Assessment of a 1940 nm Tm:YAP Laser for Fractional Skin Ablation in a Swine Model},
journal = {Lasers in Surgery and Medicine},
year = {2025},
doi = {10.1002/lsm.70022}
}
EUVIMED